Label: ADWE CHILDRENS PAIN FEVER- acetaminophen suspension
- NDC Code(s): 68163-695-04
- Packager: RARITAN PHARMACEUTICALS INC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph not final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated August 16, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredient (in each 5 mL)
- Purpose
- Uses
-
Warnings
Liver warning
This product contains acetaminophen. Severe liver damage may occur if your child takes
- ▪
- more than 5 doses in 24 hours, which is the maximum daily amount
- ▪
- with other drugs containing acetaminophen
- ▪
- Allergy alert: acetaminophen may cause severe skin reactions. Symptoms may include:
- ▪
- skin reddening
- ▪
- blisters
- ▪
- rash
If a skin reaction occurs, stop use and seek medical help right away.
Sore throat warning: if sore throat is severe, persists for more than 2 days, is accompanied, or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.
Do not use
- ▪
- with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
- ▪
- if your child is allergic to acetaminophen or any of the inactive ingredients in this product
-
Directions
- •
- this product does not contain directions or complete warnings for adult use.
- •
- do not give more than directed (see overdose warning)
- •
- shake well before using
- •
- mL = milliliter
- •
- find right dose on chart below. If possible, use weight to dose; otherwise, use age.
- •
- remove the child protective cap and squeeze your child's dose into the dosing cup
- •
- repeat dose every 4 hours while symptoms last
- •
- do not give more than 5 times in 24 hours
Weight (lb) Age (yr) Dose (mL) ** under 24
under 2 years
ask a doctor
24-35
2-3 years
5 mL
36-47
4-5 years
7.5 mL
48-59
6-8 years
10 mL
60-71
9-10 years
12.5 mL
72-95
11 years
15 mL
Attention: use only enclosed dosing cup specifically designed for use with this product. Do not use any other dosing device.
- Other information
- Inactive ingredients
- Questions or comments?
-
PRINCIPAL DISPLAY PANEL
NDC 68163-695-04
Adwe
Feverx
Children’s Pain+Fever Relief
Acetaminophen
Oral Suspension
PAIN RELIEVER-FEVER REDUCERCompare to the active ingredient in Children’s Tylenol® Dye-Free Oral Suspension*
For Ages 2-11 Years
- •
- Dye-Free
- •
- No Added Alcohol
- •
- Sugar Free
4 FL. OZ. (120 mL)
160 mg per 5 mLCHERRY FLAVOR
Naturally Flavored*This product is not manufactured or distributed by Johnson & Johnson Consumer Inc., distributer of Children’s Tylenol® Dye-Free Oral Suspension.
Manufactured for : Adwe Laboratories
1274 49 Street Brooklyn, NY 11219
-
INGREDIENTS AND APPEARANCE
ADWE CHILDRENS PAIN FEVER
acetaminophen suspensionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:68163-695 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) ACETAMINOPHEN 160 mg in 5 mL Inactive Ingredients Ingredient Name Strength ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED (UNII: K679OBS311) GLYCERIN (UNII: PDC6A3C0OX) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) WATER (UNII: 059QF0KO0R) SODIUM BENZOATE (UNII: OJ245FE5EU) TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K) SORBITOL SOLUTION (UNII: 8KW3E207O2) SUCRALOSE (UNII: 96K6UQ3ZD4) XANTHAN GUM (UNII: TTV12P4NEE) Product Characteristics Color white Score Shape Size Flavor CHERRY Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:68163-695-04 1 in 1 PACKAGE 01/17/2022 1 120 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part343 01/17/2022 Labeler - RARITAN PHARMACEUTICALS INC (127602287)